Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.

Phipatanakul W, Mauger DT, Guilbert TW, et al. "Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation." Contemp Clin Trials. 2021;100:106228.